Eric Abbate

USPTO Granted Patents = 19 (Patent Applications = 8)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 56(Granted Patents)

Location History:

Vacaville, CA (US) (2012 - 2022)
Boulder, CO (US) (2021 - 2023)

Company Filing History:

Years Active: 2012-2023

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11787841 - Rationally-designed mutations to the thrA gene for enhanced lysine production in (2023-10-17),

2. 11427847 - [object Object] (2022-08-30),

3. 11078510 - Methods for producing polypeptides in protease-deficient mutants of (2021-08-03),

4. 11078509 - Methods for producing polypeptides in protease-deficient mutants of (2021-08-03),

5. 11078508 - Methods for producing polypeptides in protease-deficient mutants of trichoderma (2021-08-03),

6. 11078458 - Genome-wide rationally-designed mutations leading to enhanced lysine production in (2021-08-03),

7. 11001869 - Methods for producing polypeptides in protease-deficient mutants of Trichoderma (2021-05-11),

8. 10920189 - Genome-wide rationally-designed mutations leading to enhanced lysine production in (2021-02-16),

9. 10883129 - Methods and compositions for degrading cellulosic material (2021-01-05),

10. 10400260 - Protease-deficient mutants offor producing polypeptides (2019-09-03),

11. 10400259 - Methods and compositions for degrading cellulosic material (2019-09-03),

12. 10059972 - Methods and compositions for degrading cellulosic material (2018-08-28),

13. 9677102 - Methods and compositions for degrading cellulosic material (2017-06-13),

14. 9145569 - Methods and compositions for degrading cellulosic material (2015-09-29),

15. 8986974 - Methods for producing polypeptidies in protease-deficient mutants of trichoderma (2015-03-24),

Title: **The Innovative Journey of Eric Abbate**

Introduction

Eric Abbate is an accomplished inventor based in Vacaville, California, known for his significant contributions to the field of biotechnology. With a remarkable portfolio of 16 patents, Abbate has focused on developing innovative solutions involving polypeptides and enzyme production.

Latest Patents

Among his latest inventions, Abbate has worked on mutants of parent strains that comprise a polynucleotide encoding a polypeptide along with several genes. These genes include various protease genes, such as subtilisin-like serine proteases and aspartic proteases. His inventions are notable for their modification processes that render the mutant strains deficient in the production of specific enzymes. These developments allow for more efficient methods of polypeptide production in protease-deficient mutants, showcasing Abbate's commitment to advancing genetic innovations.

Career Highlights

Abbate is currently employed at Novozymes, Inc., a leading company in the biotechnology sector, where he continues to develop groundbreaking solutions. Over the years, he has established a reputation for his expert knowledge and inventive approaches within his field, significantly impacting enzyme production and biotechnology.

Collaborations

Throughout his career, Abbate has collaborated with several talented colleagues, including Kimberly M. Brown and Suchindra Maiyuran. These partnerships have facilitated various innovative projects, enhancing the collective expertise within their research initiatives.

Conclusion

Eric Abbate's journey as an inventor exemplifies the spirit of innovation within the biotechnology industry. His contributions have not only resulted in a substantial number of patents but have also set new standards in enzyme development and production methods. As he continues to pursue his research, Abbate's work undoubtedly plays a key role in shaping the future of technological advancements in this field.

This text is generated by artificial intelligence and may not be accurate.